Analysis of Amdocs Ltd (DOX)
Amdocs Ltd (DOX) has been showing a downward trend in the recent days. The Relative Strength Index (RSI) is below 30, indicating an oversold condition. The Moving Average Convergence Divergence (MACD) is negative, with the MACD line below the signal line, suggesting a bearish momentum.
The stock price has been decreasing, with the price closing below the moving averages (SMA, EMA, WMA). The last closing price was 76.80, which is lower than the opening price of 77.47.
Overall, based on the technical indicators and recent price movements, Amdocs Ltd appears to be in a bearish phase. Traders and investors may consider exercising caution or implementing risk management strategies when dealing with this stock.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates remains at 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates increases to 38.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
Overall, the analysts are forecasting moderate to strong sales growth for both the upcoming quarters and the next fiscal year, with an increasing number of analysts providing estimates for the company's performance.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The estimated average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still projected to be healthy.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range of forecasts, from a low of $164 to a high of $275, indicating some uncertainty in the predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-earnings ratios, along with other valuation multiples. The market capitalization and enterprise value are also provided.
The stock price summary includes beta, moving averages, and the range of prices over the past year.
Lastly, dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics. The company has a regular dividend payment schedule and has had a recent stock split.
Income statement 💸
These are revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The EBIT (Earnings Before Interest and Taxes) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) have also shown a positive trend, indicating healthy operational performance.
3. Net income has been growing consistently, reflecting the company's profitability.
4. Despite fluctuations in other income and expenses, the company has managed to maintain a strong financial position.
5. The basic and diluted earnings per share (EPS) have remained relatively stable over the years.
6. The company has effectively managed its operating expenses, including research and development and selling, general, and administrative expenses.
7. The company has been able to generate a significant gross profit margin, although the cost of goods sold has also increased with the rise in sales.
8. Non-operating interests and expenses have had a minor impact on the company's overall financial performance.
9. The number of basic and diluted shares outstanding has remained constant, indicating no significant dilution of shares.
10. The net income from continuous operations has shown a positive growth trajectory, indicating the company's ability to generate sustainable profits.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. The current assets have fluctuated, with the highest value in 2019 at $162.8 billion and the lowest in 2023 at $135.4 billion.
3. Cash and cash equivalents have varied, reaching the highest value of $48.8 billion in 2019 and the lowest of $29.9 billion in 2023.
4. Non-current assets have shown an increasing trend, with the highest value in 2023 at $217.4 billion.
5. Total liabilities have also been increasing, from $255.4 billion in 2018 to $290.4 billion in 2023.
6. Shareholders' equity has shown fluctuations, with the highest value in 2019 at $90.5 billion and the lowest in 2018 at $65.3 billion.
7. Retained earnings have been negative in some years, indicating losses or dividend payments exceeding profits.
8. The company has been relying on debt financing, as seen from the increasing long-term debt over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchases, long-term debt issuances and payments, and dividend payments.
5. Investing activities include acquisitions, investments, and capital expenditures, with significant variations in values each year.
6. The end cash position has also been fluctuating, reaching its highest value in 2020 and its lowest in 2022.
These conclusions provide insights into the company's financial performance and management of cash flows over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This represents an increase from the EPS of $1.17 reported a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 reported in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This shows growth compared to the EPS of $5.67 in the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, analysts project an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.MACD of DOX